- Type 2 diabetes is a condition that results from the body no longer responding to insulin, the hormone that controls blood glucose levels.
- People with type 2 diabetes are at high risk of developing chronic kidney disease.
- Semaglutide — sold under the brand name Ozempic — is a drug that, in conjunction with diet and exercise, improves blood glucose (sugar) control in people with diabetes.
- Now, trial results show that semaglutide may also reduce the progression of kidney disease.
Chronic kidney disease affects
The resulting damage to blood vessels and
As the early stages of kidney disease cause few or no symptoms, people with diabetes should manage their blood glucose, blood pressure and cholesterol levels. They should also get regular checks from their doctor.
The Food and Drug Administration (FDA) has approved Ozempic as a treatment for type 2 diabetes, in addition to diet and exercise.
As well as helping control blood glucose, it may also reduce the risk of heart attack, stroke, or death in adults with type 2 diabetes and heart disease. One study has shown that it could also reduce inflammation, which may explain these other health effects.
Dr. Joshua J. Neumiller, PharmD, American Diabetes Association Board president-elect for healthcare and education, told Medical News Today that “[b]uilding evidence suggests that GLP-1 receptor agonists suppress inflammation and reduce oxidative stress and fibrosis in the kidney, together slowing [chronic kidney disease] progression.”
Now, the…
Read the full article here